Pfizer's next play: A vaccine maker and pandemic 'partner' to governments

Dow Jones2021-05-05

The company's COVID-19 vaccine generated $3.4 billion in revenue in the first quarter of 2021

Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker's top-selling drug and forging a new path into infectious diseases for the legacy drug maker.

Shares of Pfizer $(PFE)$ gained 0.2% in trading on Tuesday after the company announced earnings for the first quarter of 2021. It updated guidance to $26 billion for 2021, up from an earlier forecast for $15 billion.

To put this in perspective, the company's top-selling cholesterol pill Lipitor brought in $13 billion in annual sales at its peak, in 2006, and generated a total of $94 billion over a 15-year span, according to FiercePharma .

Here are a few additional details to pay attention to from Pfizer's first-quarter earnings:

Pfizer's stock is up 8.3% for the year, while the S&P 500 has gained 11.6%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

WeiKeong
2021-05-05
WeiKeong
Good job
Joshualoh
2021-05-05
Joshualoh
Pls help to like and comment. Thank you!
- Joshualoh:
  Thank you
- WeiKeong:
  Like
li1986
2021-05-05
li1986
Good
- Alanleejw:
  Yup

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2133528918?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-05 20:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2133528918","market":"us","top_or_hot":-1,"title":"Pfizer's next play: A vaccine maker and pandemic 'partner' to governments","media":"Dow Jones","content":"<p>The company's COVID-19 vaccine generated $3.4 billion in revenue in the first quarter of 2021</p><p>Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker's top-selling drug and forging a new path into infectious diseases for the legacy drug maker.</p><p>Shares of Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> gained 0.2% in trading on Tuesday after the company announced earnings for the first quarter of 2021. It updated guidance  to $26 billion for 2021, up from an earlier forecast for $15 billion.</p><p>To put this in perspective, the company's top-selling cholesterol pill Lipitor brought in $13 billion in annual sales at its peak, in 2006, and generated a total of $94 billion over a 15-year span, according to FiercePharma .</p><p>Here are a few additional details to pay attention to from Pfizer's first-quarter earnings:</p><p>Pfizer's stock is up 8.3% for the year, while the S&amp;P 500  has gained 11.6%.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer's next play: A vaccine maker and pandemic 'partner' to governments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer's next play: A vaccine maker and pandemic 'partner' to governments\n</h2>\n\n<h4 class=\"meta\">\n\n2021-05-05 20:11 北京时间&nbsp;&nbsp;&nbsp;<strong>Dow Jones</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The company's COVID-19 vaccine generated $3.4 billion in revenue in the first quarter of 2021Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":null,"article_id":"2133528918","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2133528918","pubTimestamp":1620216660,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"The company's COVID-19 vaccine generated $3.4 billion in revenue in the first quarter of 2021Pfizer ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞的下一个角色：疫苗制造商和政府的大流行病“合作伙伴”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"The company's COVID-19 vaccine generated $3.4 billion in revenue in the first quarter of 2021Pfizer Inc.'s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker's top-selling drug and forging a new path into infectious diseases for the legacy drug maker.Shares of Pfizer $(PFE)$ gained 0.2% in trading on Tuesday after the company announced earnings for the first quarter of 2021. It updated guidance  to $26 billion for 2021, up from an earlier forecast for $15 billion.To put this in perspective, the company's top-selling cholesterol pill Lipitor brought in $13 billion in annual sales at its peak, in 2006, and generated a total of $94 billion over a 15-year span, according to FiercePharma .Here are a few additional details to pay attention to from Pfizer's first-quarter earnings:Pfizer's stock is up 8.3% for the year, while the S&P 500  has gained 11.6%.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":102281612,"gmtCreate":1620218035536,"gmtModify":1704340306157,"author":{"id":"3574809268346931","authorId":"3574809268346931","name":"WeiKeong","avatar":"https://static.tigerbbs.com/5495c1f2e5e2d6067ea4add6d0b105c5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574809268346931","authorIdStr":"3574809268346931"},"htmlText":"Good job","listText":"Good job","text":"Good job","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102281612","repostId":2133528918,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":102217451,"gmtCreate":1620217786573,"gmtModify":1704340301095,"author":{"id":"3581542385429790","authorId":"3581542385429790","name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581542385429790","authorIdStr":"3581542385429790"},"htmlText":"Pls help to like and comment. Thank you!","listText":"Pls help to like and comment. Thank you!","text":"Pls help to like and comment. Thank you!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/102217451","repostId":2133528918,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4230779,"gmtCreate":1620218694726,"gmtModify":1680787120915,"authorId":3581542385429790,"author":{"id":3581542385429790,"idStr":"3581542385429790","authorId":3581542385429790,"name":"Joshualoh","avatar":"https://static.tigerbbs.com/c58fbad5a58ad5a9a8238280ce7e9a39","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102217451,"type":1,"supId":4230673,"prevId":0,"content":"Thank you","text":"Thank you","html":"Thank you"},{"id":4230673,"gmtCreate":1620217963422,"gmtModify":1680787116879,"authorId":3574809268346931,"author":{"id":3574809268346931,"idStr":"3574809268346931","authorId":3574809268346931,"name":"WeiKeong","avatar":"https://static.tigerbbs.com/5495c1f2e5e2d6067ea4add6d0b105c5","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.25","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102217451,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":102212757,"gmtCreate":1620217476179,"gmtModify":1704340297498,"author":{"id":"3573205405294282","authorId":"3573205405294282","name":"li1986","avatar":"https://static.tigerbbs.com/baa3fac0e4b817f045ba87890b5ab650","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3573205405294282","authorIdStr":"3573205405294282"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/102212757","repostId":2133528918,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4230647,"gmtCreate":1620217730332,"gmtModify":1680787110353,"authorId":3573201524091165,"author":{"id":3573201524091165,"idStr":"3573201524091165","authorId":3573201524091165,"name":"Alanleejw","avatar":"https://static.tigerbbs.com/e98047d5efed36f1cd5be3fcd0c6411a","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":102212757,"type":1,"supId":0,"prevId":0,"content":"Yup ","text":"Yup ","html":"Yup "}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":7,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2133528918"}